Online Registration is Open!
Register by Friday, August 21, 2015 to Save up to $300.
» View Pricing
Printed from the IBC Life Sciences Web site on August 30, 2015 8:29 PM ET.
Page location: http://www.ibclifesciences.com/Immunogenicity/overview.xml
November 09-10, 2015 · Hyatt Regency Reston · Reston, VA
Get up-to-date with the global industrial biotherapeutic community from BioProcess International™ Magazine
Special Discounted Hotel Rate Available Until October 13, 2014. To book your room, call 1-800-635-5065 and mention that you are an IBC attendee at this event.
As the longest and most comprehensive event on predicting and de-risking immune responses from concept to product, the 16th annual Immunogenicity for Biotherapeutics event delivers key insights and case studies to remove the uncertainty surrounding immune response prediction and minimization. With strategies to overcome immunogenicity challenges from pre-clinical and development all the way through post-clinical stages, this event is a "can't miss" to create reliable, predictable, and worthwhile tests to improve biologic safety.
"I was particularly impressed by this event's extremely high standards for speakers, panel discussions, networking and audience feedback." - Harald Kropshofer, Senior Personalized Healthcare Leader, F. Hoffman La Roche AG
Hear from industry leaders and meet with Senior Scientists, Research Scientists, Principal Scientists, Directors and CSO from pharmaceutical and biotech, and other specialists in the following departments:
"An excellent program - extremely useful from a technical perspective. The lessons from the case studies and discussions will assist our group's development efforts." - Thomas Klem, Scientist, Shire
This meeting provides the regulatory guidance and analytical characterization strategies you need to ensure accurate CMC submissions. For nearly two decades, this case-study driven event has led the industry by consistently providing the latest updates on the most novel bioanalytical methods for sound characterization of biologics. » Learn More